Moleculin Biotech Inc (MBRX)
5.08
+0.05
(+0.99%)
USD |
NASDAQ |
May 17, 16:00
5.08
0.00 (0.00%)
After-Hours: 20:00
Moleculin Biotech Total Liabilities (Quarterly): 9.258M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 9.258M |
| December 31, 2023 | 12.14M |
| September 30, 2023 | 4.385M |
| June 30, 2023 | 6.847M |
| March 31, 2023 | 5.378M |
| December 31, 2022 | 5.231M |
| September 30, 2022 | 6.955M |
| June 30, 2022 | 6.896M |
| March 31, 2022 | 6.136M |
| December 31, 2021 | 5.097M |
| September 30, 2021 | 7.443M |
| June 30, 2021 | 8.834M |
| March 31, 2021 | 11.27M |
| December 31, 2020 | 11.27M |
| September 30, 2020 | 12.68M |
| June 30, 2020 | 15.75M |
| March 31, 2020 | 10.18M |
| Date | Value |
|---|---|
| December 31, 2019 | 9.664M |
| September 30, 2019 | 11.42M |
| June 30, 2019 | 9.762M |
| March 31, 2019 | 6.616M |
| December 31, 2018 | 5.313M |
| September 30, 2018 | 5.931M |
| June 30, 2018 | 7.318M |
| March 31, 2018 | 4.359M |
| December 31, 2017 | 2.365M |
| September 30, 2017 | 1.982M |
| June 30, 2017 | 1.98M |
| March 31, 2017 | 4.175M |
| December 31, 2016 | 1.433M |
| September 30, 2016 | 1.330M |
| June 30, 2016 | 2.003M |
| March 31, 2016 | 0.978M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
4.385M
Minimum
Sep 2023
15.75M
Maximum
Jun 2020
8.83M
Average
9.046M
Median
Total Liabilities (Quarterly) Benchmarks
| Merck & Co Inc | 65.42B |
| Lixte Biotechnology Holdings Inc | 0.4628M |
| Moderna Inc | 3.912B |
| NovaBay Pharmaceuticals Inc | 5.197M |
| Palatin Technologies Inc | 9.827M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 30.84M |
| Shareholders Equity (Quarterly) | 21.59M |